These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 14716184
1. The effect of hormone therapy on the risk for age-related maculopathy in postmenopausal women. Abramov Y, Borik S, Yahalom C, Fatum M, Avgil G, Brzezinski A, Banin E. Menopause; 2004; 11(1):62-8. PubMed ID: 14716184 [Abstract] [Full Text] [Related]
2. Bone mineral density and age-related maculopathy in older women. Seitzman RL, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, Hochberg MC, Hillier TA, Yu F, Coleman AL, Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc; 2007 May; 55(5):740-6. PubMed ID: 17493194 [Abstract] [Full Text] [Related]
3. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS. Cancer Res; 2001 Jan 01; 61(1):126-30. PubMed ID: 11196149 [Abstract] [Full Text] [Related]
4. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women. Chan MF, Dowsett M, Folkerd E, Wareham N, Luben R, Welch A, Bingham S, Khaw KT. Menopause; 2008 Jan 01; 15(2):332-9. PubMed ID: 17667152 [Abstract] [Full Text] [Related]
5. Associated factors for age-related maculopathy in the adult population in southern India: the Andhra Pradesh Eye Disease Study. Krishnaiah S, Das TP, Kovai V, Rao GN. Br J Ophthalmol; 2009 Sep 01; 93(9):1146-50. PubMed ID: 19429580 [Abstract] [Full Text] [Related]
6. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen NV. Acta Ophthalmol Scand; 2005 Aug 01; 83(4):409-18. PubMed ID: 16029262 [Abstract] [Full Text] [Related]
7. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Wong TY, Shankar A, Klein R, Bray MS, Couper DJ, Klein BE, Sharrett AR, Folsom AR. Ophthalmology; 2006 Feb 01; 113(2):255-9. PubMed ID: 16406547 [Abstract] [Full Text] [Related]
8. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. van Leeuwen R, Tomany SC, Wang JJ, Klein R, Mitchell P, Hofman A, Klein BE, Vingerling JR, Cumming RG, de Jong PT. Ophthalmology; 2004 Jun 01; 111(6):1169-75. PubMed ID: 15177967 [Abstract] [Full Text] [Related]
9. Hormone replacement therapy, reproductive factors, and age-related macular degeneration: the Salisbury Eye Evaluation Project. Freeman EE, Muñoz B, Bressler SB, West SK. Ophthalmic Epidemiol; 2005 Feb 01; 12(1):37-45. PubMed ID: 15848919 [Abstract] [Full Text] [Related]
10. Postmenopausal hormone therapy and migraine headache. Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, Rexrode KM. J Womens Health (Larchmt); 2003 Dec 01; 12(10):1027-36. PubMed ID: 14709191 [Abstract] [Full Text] [Related]
11. The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005. Cho GJ, Park HT, Shin JH, Kim T, Hur JY, Kim YT, Lee KW, Kim SH. Menopause; 2009 Dec 01; 16(5):998-1003. PubMed ID: 19407665 [Abstract] [Full Text] [Related]
12. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease. Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM. Menopause; 2008 Dec 01; 15(6):1060-4. PubMed ID: 18521047 [Abstract] [Full Text] [Related]
13. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Im JA, Lee JW, Lee HR, Lee DC. Maturitas; 2006 Apr 20; 54(1):65-71. PubMed ID: 16198517 [Abstract] [Full Text] [Related]
14. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease. Windler E, Zyriax BC, Eidenmüller B, Boeing H. Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571 [Abstract] [Full Text] [Related]
15. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration. Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group. Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339 [Abstract] [Full Text] [Related]
18. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G. Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533 [Abstract] [Full Text] [Related]
19. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Wolf LA, Terry PD, Potter JD, Bostick RM. Cancer Epidemiol Biomarkers Prev; 2007 Apr 11; 16(4):676-83. PubMed ID: 17416757 [Abstract] [Full Text] [Related]
20. Five-year incidence of age-related maculopathy: the Visual Impairment Project. Mukesh BN, Dimitrov PN, Leikin S, Wang JJ, Mitchell P, McCarty CA, Taylor HR. Ophthalmology; 2004 Jun 11; 111(6):1176-82. PubMed ID: 15177968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]